Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 142 articles: HTML format Text format

Single Articles

June 2018
1. MAO Y, Feng Q, Zheng P, Yang L, et al
   Low Tumor Infiltrating Mast Cell Density Confers Prognostic Benefit and Reflects Immunoactivation in Colorectal Cancer.
   Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31613.
   PubMed     Text format     Abstract available
   
   
   
2. FORMICA V, Zaniboni A, Loupakis F, Roselli M, et al
   Non-inferiority of three months vs six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?
   Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31616.
   PubMed     Text format     Abstract available
   
   
   May 2018
3. GYLLING B, Myte R, Ulvik A, Ueland PM, et al
   One-carbon metabolite ratios as functional B-vitamin markers and in relation to colorectal cancer risk.
   Int J Cancer. 2018 May 22. doi: 10.1002/ijc.31606.
   PubMed     Text format     Abstract available
   
   
   
4. TAYLOR ES, McCall JL, Shen S, Girardin A, et al
   Prognostic roles for IL-2-producing and CD69(+) T cell subsets in colorectal cancer patients.
   Int J Cancer. 2018 May 11. doi: 10.1002/ijc.31598.
   PubMed     Text format     Abstract available
   
   
   April 2018
5. MURPHY N, Achaintre D, Zamora-Ros R, Jenab M, et al
   A Prospective Evaluation of Plasma Polyphenol Levels and Colon Cancer Risk.
   Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31563.
   PubMed     Text format     Abstract available
   
   
   
6. CHEN L, Pan X, Hu X, Zhang YH, et al
   Gene expression differences among different MSI statuses in colorectal cancer.
   Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31554.
   PubMed     Text format     Abstract available
   
   
   
7. BARRUBES L, Babio N, Mena-Sanchez G, Toledo E, et al
   Dairy product consumption and risk of colorectal cancer in an older Mediterranean population at high cardiovascular risk.
   Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31540.
   PubMed     Text format     Abstract available
   
   
   
8. TRIFF K, McLean MW, Callaway E, Goldsby J, et al
   Dietary fat and fiber interact to uniquely modify global histone post-translational epigenetic programming in a rat colon cancer progression model.
   Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31525.
   PubMed     Text format     Abstract available
   
   
   
9. LIU X, Zhou W, Zhang X, Ding Y, et al
   1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
   Int J Cancer. 2018 Apr 1. doi: 10.1002/ijc.31417.
   PubMed     Text format     Abstract available
   
   
   March 2018
10. LI X, Guo X, Li D, Du X, et al
    Multi-regional Sequencing Reveals Intratumor Heterogeneity and Positive Selection of Somatic mtDNA Mutations in Hepatocellular Carcinoma and Colorectal Cancer.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31395.
    PubMed     Text format     Abstract available
    
    
    
11. FADDA A, Gentilini D, Moi L, Barault L, et al
    Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor.
    Int J Cancer. 2018 Mar 15. doi: 10.1002/ijc.31380.
    PubMed     Text format     Abstract available
    
    
    
12. ZHOU M, Liu X, Li Z, Huang Q, et al
    Caspase-3 regulates the migration, invasion, and metastasis of colon cancer cells.
    Int J Cancer. 2018 Mar 10. doi: 10.1002/ijc.31374.
    PubMed     Text format     Abstract available
    
    
    
13. PAN P, Oshima K, Huang YW, Agle KA, et al
    Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.
    Int J Cancer. 2018 Mar 9. doi: 10.1002/ijc.31366.
    PubMed     Text format     Abstract available
    
    
    February 2018
14. MARQUEZ J, Fernandez-Pineiro I, Arauzo-Bravo MJ, Poschmann G, et al
    Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver.
    Int J Cancer. 2018 Feb 28. doi: 10.1002/ijc.31343.
    PubMed     Text format     Abstract available
    
    
    
15. KABAT GC, Kim MY, Stefanick M, Ho GYF, et al
    Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women.
    Int J Cancer. 2018 Feb 27. doi: 10.1002/ijc.31345.
    PubMed     Text format     Abstract available
    
    
    
16. SHU X, Xiang YB, Rothman N, Yu D, et al
    Prospective study of blood metabolites associated with colorectal cancer risk.
    Int J Cancer. 2018 Feb 26. doi: 10.1002/ijc.31341.
    PubMed     Text format     Abstract available
    
    
    
17. WU S, Meng Q, Zhang C, Sun H, et al
    DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus.
    Int J Cancer. 2018 Feb 15. doi: 10.1002/ijc.31318.
    PubMed     Text format     Abstract available
    
    
    
18. KASHINO I, Akter S, Mizoue T, Sawada N, et al
    Coffee drinking and colorectal cancer and its subsites: A pooled analysis of 8 cohort studies in Japan.
    Int J Cancer. 2018 Feb 15. doi: 10.1002/ijc.31320.
    PubMed     Text format     Abstract available
    
    
    
19. LEW JB, James D, St John B, Macrae FA, et al
    Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31314.
    PubMed     Text format     Abstract available
    
    
    
20. AMSHOFF Y, Maskarinec G, Shvetsov YB, Raquinio PH, et al
    Type 2 Diabetes and Colorectal Cancer Survival: The Multiethnic Cohort.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31311.
    PubMed     Text format     Abstract available
    
    
    
21. SCHULLEHNER J, Hansen B, Thygesen M, Pedersen CB, et al
    Nitrate in drinking water and colorectal cancer risk: A nationwide population-based cohort study.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31306.
    PubMed     Text format     Abstract available
    
    
    
22. FRANSGAARD T, Thygesen LC, Gogenur I
    Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register-based study.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31305.
    PubMed     Text format     Abstract available
    
    
    January 2018
23. O'BRIEN SJ, Carter JV, Burton JF, Oxford BG, et al
    The role of the miR-200 Family in Epithelial-Mesenchymal Transition in Colorectal Cancer: A Systematic Review.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31282.
    PubMed     Text format     Abstract available
    
    
    
24. ISHIKAWA T, Okayama T, Sakamoto N, Ideno M, et al
    Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31285.
    PubMed     Text format     Abstract available
    
    
    
25. BUTT J, Jenab M, Willhauck-Fleckenstein M, Michel A, et al
    Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer.
    Int J Cancer. 2018 Jan 29. doi: 10.1002/ijc.31283.
    PubMed     Text format     Abstract available
    
    
    
26. MA H, Wu Z, Peng J, Li Y, et al
    Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab.
    Int J Cancer. 2018 Jan 24. doi: 10.1002/ijc.31274.
    PubMed     Text format     Abstract available
    
    
    
27. VAN SEBILLE YZA, Gibson RJ, Wardill HR, Ball IA, et al
    Dacomitinib-induced diarrhea: Targeting chloride secretion with crofelemer.
    Int J Cancer. 2018;142:369-380.
    PubMed     Text format     Abstract available
    
    
    
28. BASU P, Ponti A, Anttila A, Ronco G, et al
    Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.
    Int J Cancer. 2018;142:44-56.
    PubMed     Text format     Abstract available
    
    
    December 2017
29. GIES A, Bhardwaj M, Stock C, Schrotz-King P, et al
    Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31233.
    PubMed     Text format     Abstract available
    
    
    
30. LIU W, Wang S, Sun Q, Yang Z, et al
    DCLK1 Promotes Epithelial-Mesenchymal Transition via the PI3K/Akt/NF-kappaB Pathway in Colorectal Cancer.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31232.
    PubMed     Text format     Abstract available
    
    
    
31. JI J, Sundquist J, Sundquist K
    Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
    Int J Cancer. 2017 Dec 22. doi: 10.1002/ijc.31228.
    PubMed     Text format     Abstract available
    
    
    
32. FENG HC, Lin JY, Hsu SH, Lan WY, et al
    Low folate metabolic stress reprograms DNA methylation-activated sonic hedgehog signaling to mediate cancer stem cell-like signatures and invasive tumour stage-specific malignancy of human colorectal cancers.
    Int J Cancer. 2017;141:2537-2550.
    PubMed     Text format     Abstract available
    
    
    
33. ZHOU R, Shao Z, Liu J, Zhan W, et al
    COPS5 and LASP1 Synergistically Interact to Down-regulate 14-3-3sigma Expression and Promote Colorectal Cancer Progression via Activating PI3K/AKT Pathway.
    Int J Cancer. 2017 Dec 11. doi: 10.1002/ijc.31206.
    PubMed     Text format     Abstract available
    
    
    
34. SCHWINGSHACKL L, Schwedhelm C, Hoffmann G, Knuppel S, et al
    Food groups and risk of colorectal cancer.
    Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31198.
    PubMed     Text format     Abstract available
    
    
    
35. RAY AL, Berggren KL, Restrepo Cruz S, Gan GN, et al
    Inhibition of MK2 suppresses IL-1beta, IL-6, and TNF-alpha dependent colorectal cancer growth.
    Int J Cancer. 2017 Dec 2. doi: 10.1002/ijc.31191.
    PubMed     Text format     Abstract available
    
    
    November 2017
36. BABAEI M, Balavarca Y, Jansen L, Lemmens V, et al
    Administration of Adjuvant Chemotherapy for Stage II-III Colon Cancer Patients: A European Population-based Study.
    Int J Cancer. 2017 Nov 21. doi: 10.1002/ijc.31168.
    PubMed     Text format     Abstract available
    
    
    
37. YAMAUCHI M, Urabe Y, Ono A, Miki D, et al
    Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients.
    Int J Cancer. 2017 Nov 14. doi: 10.1002/ijc.31154.
    PubMed     Text format     Abstract available
    
    
    
38. DI J, Yang H, Jiang B, Wang Z, et al
    Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
    Int J Cancer. 2017 Nov 6. doi: 10.1002/ijc.31140.
    PubMed     Text format     Abstract available
    
    
    October 2017
39. ZHANG QL, Zhao LG, Li HL, Gao J, et al
    The joint effects of major lifestyle factors on colorectal cancer risk among Chinese men: A prospective cohort study.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31126.
    PubMed     Text format     Abstract available
    
    
    
40. HOLCH JW, Ricard I, Stintzing S, Fischer von Weikersthal L, et al
    Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31114.
    PubMed     Text format     Abstract available
    
    
    
41. NIELL N, Larriba MJ, Ferrer-Mayorga G, Sanchez-Perez I, et al
    The human PKP2/Plakophilin-2 gene is induced by Wnt/beta-catenin in normal and colon cancer-associated fibroblasts.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31104.
    PubMed     Text format     Abstract available
    
    
    
42. HIDAYAT K, Yang CM, Shi BM
    Body Fatness at an Early Age and Risk of Colorectal Cancer.
    Int J Cancer. 2017 Oct 12. doi: 10.1002/ijc.31100.
    PubMed     Text format     Abstract available
    
    
    
43. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    PubMed     Text format     Abstract available
    
    
    
44. VARGAS-PARRA GM, Gonzalez-Acosta M, Thompson BA, Gomez C, et al
    Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Int J Cancer. 2017;141:1365-1380.
    PubMed     Text format     Abstract available
    
    
    September 2017
45. TANSKANEN T, van den Berg L, Valimaki N, Aavikko M, et al
    Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.
    Int J Cancer. 2017 Sep 28. doi: 10.1002/ijc.31076.
    PubMed     Text format     Abstract available
    
    
    
46. POTHOULAKIS C, Torre-Rojas M, Duran-Padilla MA, Gevorkian J, et al
    CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
    Int J Cancer. 2017 Sep 20. doi: 10.1002/ijc.31064.
    PubMed     Text format     Abstract available
    
    
    
47. WANG W, Xiao X, Chen X, Huo Y, et al
    Tumor-suppressive miR-145 co-repressed by TCF4-beta-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31056.
    PubMed     Text format     Abstract available
    
    
    
48. JAYASEKARA H, English DR, Haydon A, Hodge AM, et al
    Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31049.
    PubMed     Text format     Abstract available
    
    
    
49. HASENOEHRL C, Feuersinger D, Sturm EM, Barnthaler T, et al
    G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.
    Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31030.
    PubMed     Text format     Abstract available
    
    
    
50. MA B, Gao P, Wang H, Xu Q, et al
    What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long-term outcomes over the past decades? A systematic review and meta-analysis based on 41,121 patients.
    Int J Cancer. 2017;141:1052-1065.
    PubMed     Text format     Abstract available
    
    
    
51. VEDELD HM, Merok M, Jeanmougin M, Danielsen SA, et al
    CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
    Int J Cancer. 2017;141:967-976.
    PubMed     Text format     Abstract available
    
    
    August 2017
52. MOMEN-HERAVI F, Masugi Y, Qian ZR, Nishihara R, et al
    Tumor Expression of Calcium Sensing Receptor (CASR) and Colorectal Cancer Survival: Results from the Nurses' Health Study and Health Professionals Follow-Up Study.
    Int J Cancer. 2017 Aug 30. doi: 10.1002/ijc.31021.
    PubMed     Text format     Abstract available
    
    
    
53. EKLOF V, Lofgren-Burstrom A, Zingmark C, Edin S, et al
    Cancer associated faecal microbial markers in colorectal cancer detection.
    Int J Cancer. 2017 Aug 22. doi: 10.1002/ijc.31011.
    PubMed     Text format     Abstract available
    
    
    
54. CESPEDES FELICIANO EM, Prentice RL, Aragaki AK, Neuhouser ML, et al
    Methodological Considerations for Disentangling a Risk Factor's Influence on Disease Incidence versus Post-Diagnosis Survival: The Example of Obesity and Breast and Colorectal Cancer Mortality in the Women's Health Initiative.
    Int J Cancer. 2017 Aug 18. doi: 10.1002/ijc.30931.
    PubMed     Text format     Abstract available
    
    
    
55. MEESTER RGS, Doubeni CA, Zauber AG, van Ballegooijen M, et al
    Impact of Adenoma Detection on the Benefit of Faecal Testing versus Colonoscopy for Colorectal Cancer.
    Int J Cancer. 2017 Aug 17. doi: 10.1002/ijc.30933.
    PubMed     Text format     Abstract available
    
    
    
56. JUBRAN R, Kocsis J, Garam N, Malati E, et al
    Circulating mitochondrial Stress-70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.
    Int J Cancer. 2017 Aug 9. doi: 10.1002/ijc.30918.
    PubMed     Text format     Abstract available
    
    
    July 2017
57. JIAO W, Leng X, Zhou Q, Wu Y, et al
    Different miR-21-3p isoforms and their different features in colorectal cancer.
    Int J Cancer. 2017 Jul 22. doi: 10.1002/ijc.30902.
    PubMed     Text format     Abstract available
    
    
    
58. SCHIRRIPA M, Zhang W, Heinemann V, Cao S, et al
    Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.
    Int J Cancer. 2017;141:383-392.
    PubMed     Text format     Abstract available
    
    
    
59. GU F, Zhang H, Hyland PL, Berndt S, et al
    Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30883.
    PubMed     Text format     Abstract available
    
    
    
60. BERNTSSON J, Svensson MC, Leandersson K, Nodin B, et al
    The Clinical Impact of Tumour-infiltrating Lymphocytes in Colorectal Cancer Differs by Anatomical Subsite: A Cohort Study.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30869.
    PubMed     Text format     Abstract available
    
    
    
61. KRILAVICIUTE A, Stock C, Brenner H
    International variation in the prevalence of preclinical colorectal cancer: Implications for predictive values of noninvasive screening tests and potential target populations for screening.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30867.
    PubMed     Text format     Abstract available
    
    
    
62. ALAM KJ, Mo JS, Han SH, Park WC, et al
    MicroRNA 375 regulates proliferation and migration of colon cancer cells by suppressing the CTGF-EGFR signaling pathway.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30861.
    PubMed     Text format     Abstract available
    
    
    
63. CABEL L, Bidard FC, Servois V, Cacheux W, et al
    HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30863.
    PubMed     Text format     Abstract available
    
    
    June 2017
64. LAUDATO S, Patil N, Abba ML, Leupold JH, et al
    P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.
    Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30854.
    PubMed     Text format     Abstract available
    
    
    
65. VAN SEBILLE YZA, Gibson RJ, Wardill HR, Secombe KR, et al
    Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats.
    Int J Cancer. 2017;140:2820-2829.
    PubMed     Text format     Abstract available
    
    
    
66. YANG Y, Wang G, He J, Ren S, et al
    Gender differences in colorectal cancer survival: A Meta-analysis.
    Int J Cancer. 2017 Jun 9. doi: 10.1002/ijc.30827.
    PubMed     Text format     Abstract available
    
    
    May 2017
67. OKAZAKI S, Stintzing S, Sunakawa Y, Cao S, et al
    Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30810.
    PubMed     Text format     Abstract available
    
    
    
68. WANG N, Lu Y, Khankari NK, Long J, et al
    Evaluation of genetic variants in association with colorectal cancer risk and survival in Asians.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30812.
    PubMed     Text format     Abstract available
    
    
    
69. CANAVESE M, Ngo DT, Maddern GJ, Hardingham JE, et al
    Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer.
    Int J Cancer. 2017;140:2183-2191.
    PubMed     Text format     Abstract available
    
    
    
70. SNAEBJORNSSON P, Jonasson L, Olafsdottir EJ, van Grieken NCT, et al
    Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years.
    Int J Cancer. 2017 May 6. doi: 10.1002/ijc.30766.
    PubMed     Text format     Abstract available
    
    
    
71. BUTT J, Werner S, Willhauck-Fleckenstein M, Michel A, et al
    Serology of Streptococcus gallolyticus subspecies gallolyticus and its association with colorectal cancer and precursors.
    Int J Cancer. 2017 May 6. doi: 10.1002/ijc.30765.
    PubMed     Text format     Abstract available
    
    
    
72. BRENNER H, Niedermaier T, Chen H
    Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin.
    Int J Cancer. 2017;140:2015-2022.
    PubMed     Text format     Abstract available
    
    
    April 2017
73. BJERRUM A, Andersen O, Fischer A, Lindebjerg J, et al
    Long term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
    Int J Cancer. 2017 Apr 30. doi: 10.1002/ijc.30756.
    PubMed     Text format     Abstract available
    
    
    
74. SENDA NAKAGAWA H, Ito H, Hosono S, Oze I, et al
    Coffee consumption and the risk of colorectal cancer by anatomical subsite in Japan: Results from the HERPACC studies.
    Int J Cancer. 2017 Apr 20. doi: 10.1002/ijc.30746.
    PubMed     Text format     Abstract available
    
    
    
75. MODEST DP, Stintzing S, Fischer von Weikersthal L, Decker T, et al
    Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306).
    Int J Cancer. 2017;140:1918-1925.
    PubMed     Text format     Abstract available
    
    
    
76. BEDIN C, Enzo MV, Del Bianco P, Pucciarelli S, et al
    Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Int J Cancer. 2017;140:1888-1898.
    PubMed     Text format     Abstract available
    
    
    
77. ROMAGUERA D, Gracia-Lavedan E, Molinuevo A, de Batlle J, et al
    Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control study.
    Int J Cancer. 2017 Apr 5. doi: 10.1002/ijc.30722.
    PubMed     Text format     Abstract available
    
    
    
78. JANSEN L, Weberpals J, Kuiper JG, Vissers PA, et al
    Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30717.
    PubMed     Text format     Abstract available
    
    
    
79. JAYASEKARA H, MacInnis RJ, Williamson EJ, Hodge AM, et al
    Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer.
    Int J Cancer. 2017;140:1485-1493.
    PubMed     Text format     Abstract available
    
    
    
80. KUAN FC, Lai CH, Ku HY, Wu CF, et al
    The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation.
    Int J Cancer. 2017;140:1662-1669.
    PubMed     Text format     Abstract available
    
    
    
81. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    PubMed     Text format     Abstract available
    
    
    March 2017
82. RODRIGUEZ-BROADBENT H, Law PJ, Sud A, Palin K, et al
    Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.
    Int J Cancer. 2017 Mar 24. doi: 10.1002/ijc.30709.
    PubMed     Text format     Abstract available
    
    
    
83. ZHU XH, Wang JM, Yang SS, Wang FF, et al
    Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30701.
    PubMed     Text format     Abstract available
    
    
    
84. ZHANG L, Li L, Gao G, Wei G, et al
    Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
    Int J Cancer. 2017 Mar 17. doi: 10.1002/ijc.30698.
    PubMed     Text format     Abstract available
    
    
    
85. DIETER SM, Giessler KM, Kriegsmann M, Dubash TD, et al
    Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.
    Int J Cancer. 2017;140:1356-1363.
    PubMed     Text format     Abstract available
    
    
    
86. WILHELMSEN M, Christensen IJ, Rasmussen L, Jorgensen LN, et al
    Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
    Int J Cancer. 2017;140:1436-1446.
    PubMed     Text format     Abstract available
    
    
    
87. WANG H, Schmit SL, Haiman CA, Keku TO, et al
    Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.
    Int J Cancer. 2017 Mar 13. doi: 10.1002/ijc.30687.
    PubMed     Text format     Abstract available
    
    
    
88. FIDLER MM, Bray F, Vaccarella S, Soerjomataram I, et al
    Assessing global transitions in human development and colorectal cancer incidence.
    Int J Cancer. 2017 Mar 9. doi: 10.1002/ijc.30686.
    PubMed     Text format     Abstract available
    
    
    
89. KEUM N, Yuan C, Nishihara R, Zoltick E, et al
    Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30683.
    PubMed     Text format     Abstract available
    
    
    February 2017
90. KIRANA C, Ruszkiewicz A, Stubbs RS, Hardingham JE, et al
    Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30667.
    PubMed     Text format     Abstract available
    
    
    
91. JERZAK KJ, Berry S, Ko YJ, Earle C, et al
    Cetuximab plus Irinotecan versus Panitumumab in Patients with refractory metastatic colorectal cancer in Ontario, Canada.
    Int J Cancer. 2017 Feb 21. doi: 10.1002/ijc.30637.
    PubMed     Text format     Abstract available
    
    
    
92. ZHANG D, Zhao L, Shen Q, Lv Q, et al
    Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30656.
    PubMed     Text format     Abstract available
    
    
    
93. FASANELLI F, Zugna D, Giraudo MT, Krogh V, et al
    Abdominal adiposity is not a mediator of the protective effect of Mediterranean Diet on colorectal cancer.
    Int J Cancer. 2017 Feb 16. doi: 10.1002/ijc.30653.
    PubMed     Text format     Abstract available
    
    
    
94. MORRIS SM, Davison J, Carter KT, O'Leary RM, et al
    Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Int J Cancer. 2017;140:853-863.
    PubMed     Text format     Abstract available
    
    
    
95. CUBIELLA J, Digby J, Rodriguez-Alonso L, Vega P, et al
    The FAST (Faecal Haemoglobin Concentration, Age and Sex Test) Score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30639.
    PubMed     Text format     Abstract available
    
    
    January 2017
96. HERBST A, Vdovin N, Gacesa S, Philipp A, et al
    Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30625.
    PubMed     Text format     Abstract available
    
    
    
97. WALTER V, Jansen L, Knebel P, Chang-Claude J, et al
    Physical activity and survival of colorectal cancer patients: Population-based study from Germany.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30619.
    PubMed     Text format     Abstract available
    
    
    
98. ERTEM FU, Zhang W, Chang K, Mohaiza Dashwood W, et al
    Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.
    Int J Cancer. 2017;140:460-468.
    PubMed     Text format     Abstract available
    
    
    December 2016
99. ZAMORA-ROS R, Barupal D, Rothwell JA, Jenab M, et al
    Dietary Flavonoid Intake and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30582.
    PubMed     Text format     Abstract available
    
    
    
100. SEFRIOUI D, Vermeulin T, Blanchard F, Chapusot C, et al
     Copy Number Variations in DCC/18q and ERBB2/17q are Associated with Disease-Free Survival in Microsatellite Stable Colon Cancer.
     Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30584.
     PubMed     Text format     Abstract available
     
     
     
101. MORI K, Toiyama Y, Otake K, Fujikawa H, et al
     Proteomics analysis of differential protein expression identifies Heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
     Int J Cancer. 2016 Dec 7. doi: 10.1002/ijc.30557.
     PubMed     Text format     Abstract available
     
     
     
102. WANG C, Wang Z, Zhou J, Liu S, et al
     TUC.338 promotes invasion and metastasis in colorectal cancer.
     Int J Cancer. 2016 Dec 3. doi: 10.1002/ijc.30542.
     PubMed     Text format     Abstract available
     
     
     November 2016
103. BURON PUST A, Alison R, Blanks R, Pirie K, et al
     Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women.
     Int J Cancer. 2016 Nov 18. doi: 10.1002/ijc.30527.
     PubMed     Text format     Abstract available
     
     
     
104. ALGARS A, Sundstrom J, Lintunen M, Jokilehto T, et al
     EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer.
     Int J Cancer. 2016 Nov 5. doi: 10.1002/ijc.30507.
     PubMed     Text format     Abstract available
     
     
     
105. CHEN Y, Xie Y, Xu L, Zhan S, et al
     Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics.
     Int J Cancer. 2016 Nov 3. doi: 10.1002/ijc.30496.
     PubMed     Text format     Abstract available
     
     
     October 2016
106. MOMEN-HERAVI F, Babic A, Tworoger SS, Zhang L, et al
     Periodontal disease, tooth loss, and colorectal cancer risk: Results from the Nurses' Health Study.
     Int J Cancer. 2016 Oct 25. doi: 10.1002/ijc.30486.
     PubMed     Text format     Abstract available
     
     
     
107. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
     Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
     Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
     PubMed     Text format     Abstract available
     
     
     
108. WANG N, Khankari NK, Cai H, Li HL, et al
     Pre-diagnosis Body Mass Index and Waist-Hip Circumference Ratio in Association with Colorectal Cancer Survival.
     Int J Cancer. 2016 Oct 5. doi: 10.1002/ijc.30459.
     PubMed     Text format     Abstract available
     
     
     September 2016
109. SCLAFANI F, Kim TY, Cunningham D, Kim TW, et al
     Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.
     Int J Cancer. 2016 Sep 28. doi: 10.1002/ijc.30453.
     PubMed     Text format     Abstract available
     
     
     
110. SIMONS CC, Schouten LJ, Godschalk RW, van Engeland M, et al
     Energy restriction at young age, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk in the Netherlands Cohort Study.
     Int J Cancer. 2016 Sep 20. doi: 10.1002/ijc.30439.
     PubMed     Text format     Abstract available
     
     
     
111. MAIERTHALER M, Benner A, Hoffmeister M, Surowy H, et al
     Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
     Int J Cancer. 2016 Sep 15. doi: 10.1002/ijc.30433.
     PubMed     Text format     Abstract available
     
     
     
112. VAN ERNING FN, Janssen-Heijnen ML, Creemers GJ, Pruijt JF, et al
     Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy.
     Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30423.
     PubMed     Text format     Abstract available
     
     
     
113. PARK C, Kim JI, Hong SN, Jung HM, et al
     A copy number variation in PKD1L2 is associated with colorectal cancer predisposition in Korean population.
     Int J Cancer. 2016 Sep 8. doi: 10.1002/ijc.30421.
     PubMed     Text format     Abstract available
     
     
     August 2016
114. PENG F, Hu D, Lin X, Chen G, et al
     Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.
     Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30404.
     PubMed     Text format     Abstract available
     
     
     
115. LI Q, Wei P, Huang B, Xu Y, et al
     MAEL expression links epithelial-mesenchymal transition and stem cell properties in colorectal cancer.
     Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30388.
     PubMed     Text format     Abstract available
     
     
     
116. HASHIMOTO M, Kobayashi T, Tashiro H, Arihiro K, et al
     h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
     Int J Cancer. 2016;139:812-23.
     PubMed     Text format     Abstract available
     
     
     
117. TAKAHASHI Y, Sugai T, Habano W, Ishida K, et al
     Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer.
     Int J Cancer. 2016 Aug 10. doi: 10.1002/ijc.30377.
     PubMed     Text format     Abstract available
     
     
     July 2016
118. JARY M, Lecomte T, Bouche O, Kim S, et al
     Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: A simple biological score.
     Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30367.
     PubMed     Text format     Abstract available
     
     
     
119. SALIMZADEH H, Bishehsari F, Amani M, Ansari R, et al
     Advanced Colonic Neoplasia in the First Degree Relatives of Colon Cancer Patients: A Colonoscopy-based Study.
     Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30366.
     PubMed     Text format     Abstract available
     
     
     
120. ZHANG X, Keum N, Wu K, Smith-Warner SA, et al
     Calcium intake and colorectal cancer risk: Results from the Nurses' Health Study and Health Professionals Follow-up Study.
     Int J Cancer. 2016 Jul 28. doi: 10.1002/ijc.30293.
     PubMed     Text format     Abstract available
     
     
     
121. WEIGL K, Jansen L, Chang-Claude J, Knebel P, et al
     Family history and the risk of colorectal cancer: The importance of patients' history of colonoscopy.
     Int J Cancer. 2016 Jul 26. doi: 10.1002/ijc.30284.
     PubMed     Text format     Abstract available
     
     
     
122. SOREIDE K
     Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials.
     Int J Cancer. 2016 Jul 12. doi: 10.1002/ijc.30244.
     PubMed     Text format    
     
     
     
123. KAHLERT UD, Mooney SM, Natsumeda M, Steiger HJ, et al
     Targeting Cancer Stem-like Cells in Glioblastoma and Colorectal Cancer through Metabolic Pathways.
     Int J Cancer. 2016 Jul 8. doi: 10.1002/ijc.30259.
     PubMed     Text format     Abstract available
     
     
     June 2016
124. KANTOR ED, Zhang X, Wu K, Signorello LB, et al
     Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals Follow-up Study.
     Int J Cancer. 2016 Jun 30. doi: 10.1002/ijc.30250.
     PubMed     Text format     Abstract available
     
     
     
125. LAM-BOER J', Van der Geest LG, Verhoef C, Elferink ME, et al
     Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in The Netherlands.
     Int J Cancer. 2016 Jun 24. doi: 10.1002/ijc.30240.
     PubMed     Text format     Abstract available
     
     
     
126. MEULENDIJKS D, Henricks LM, Amstutz U, Froehlich TK, et al
     Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicity.
     Int J Cancer. 2016;138:2752-61.
     PubMed     Text format     Abstract available
     
     
     
127. ALLAIRE JM, Roy SA, Ouellet C, Lemieux E, et al
     Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from polyposis initiation.
     Int J Cancer. 2016;138:2700-12.
     PubMed     Text format     Abstract available
     
     
     May 2016
128. DUFFY AG, Makarova-Rusher OV, Ulahannan SV, Rahma OE, et al
     Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750 - an antisense oligonucleotide against eIF4E - in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer.
     Int J Cancer. 2016 May 19. doi: 10.1002/ijc.30199.
     PubMed     Text format     Abstract available
     
     
     April 2016
129. VILLACIS RA, Miranda PM, Gomy I, Santos EM, et al
     Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.
     Int J Cancer. 2016;138:1928-35.
     PubMed     Text format     Abstract available
     
     
     
130. UBILLOS L, Freire T, Berriel E, Chiribao ML, et al
     Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers.
     Int J Cancer. 2016;138:1719-31.
     PubMed     Text format     Abstract available
     
     
     
131. EEFSEN RL, Engelholm L, Willemoe GL, Van den Eynden GG, et al
     Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
     Int J Cancer. 2016;138:1777-84.
     PubMed     Text format     Abstract available
     
     
     
132. SAKAI E, Fukuyo M, Ohata K, Matsusaka K, et al
     Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
     Int J Cancer. 2016;138:1634-44.
     PubMed     Text format     Abstract available
     
     
     March 2016
133. LOES IM, Immervoll H, Sorbye H, Angelsen JH, et al
     Impact of KRAS, BRAF, PIK3CA, TP53 status and intra-individual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
     Int J Cancer. 2016 Mar 16. doi: 10.1002/ijc.30089.
     PubMed     Text format     Abstract available
     
     
     
134. KANGWAN N, Kim YJ, Han YM, Jeong M, et al
     Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.
     Int J Cancer. 2016;138:1482-93.
     PubMed     Text format     Abstract available
     
     
     
135. RENAUD F, Mariette C, Vincent A, Wacrenier A, et al
     The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
     Int J Cancer. 2016;138:1472-81.
     PubMed     Text format     Abstract available
     
     
     
136. IZANO M, Wei EK, Tai C, Swede H, et al
     Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
     Int J Cancer. 2016;138:1118-28.
     PubMed     Text format     Abstract available
     
     
     
137. DE CUBA EM, Snaebjornsson P, Heideman DA, van Grieken NC, et al
     Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
     Int J Cancer. 2016;138:1139-45.
     PubMed     Text format     Abstract available
     
     
     
138. BU Y, Li X, He Y, Huang C, et al
     A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation.
     Int J Cancer. 2016;138:1186-98.
     PubMed     Text format     Abstract available
     
     
     February 2016
139. MEGE D, Panicot-Dubois L, Ouaissi M, Robert S, et al
     The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study.
     Int J Cancer. 2016;138:939-48.
     PubMed     Text format     Abstract available
     
     
     January 2016
140. HOBAUS J, Tennakoon S, Heffeter P, Groeschel C, et al
     Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy.
     Int J Cancer. 2016;138:440-50.
     PubMed     Text format     Abstract available
     
     
     
141. CARR PR, Walter V, Brenner H, Hoffmeister M, et al
     Meat subtypes and their association with colorectal cancer: Systematic review and meta-analysis.
     Int J Cancer. 2016;138:293-302.
     PubMed     Text format     Abstract available
     
     
     August 2015
142. AMAYIRI N, Tabori U, Campbell B, Bakry D, et al
     High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan.
     Int J Cancer. 2015 Aug 8. doi: 10.1002/ijc.29724.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: